With Increased High-Risk Pregnancy Cases, Sophisticated Fetal Monitoring Technologies to Reach $10.9 Billion in 2019

BCC Research (http://www.bccresearch.com) reveals in its new report on fetal monitoring, diagnostics and predictive tests, that since the last decade there has been an increase of high-risk pregnancies that has necessitated the applications of high level fetal and maternal monitoring during pregnancies around the globe. With such growing demand for fetal monitoring technologies, healthcare vendors are constantly developing and offering new technologies to meet the challenges posed by complicated pregnancies.
Pregnancies become complicated due to change in lifestyle of women, conception after age 35 or when the women are just in their teens, obesity and diabetes in the child-bearing age and the success of assisted-reproduction. As nearly as 80% of live births are associated with a pregnancy-related complication, and in most delivery care settings, fetal monitoring has become a standard of care.
Fetal monitoring is usually performed with an electronic fetal heart rate monitor (FHR) or a hand-held Doppler device or a fetoscope. Electronic fetal monitors is estimated to grow from nearly $531.3 million in 2013 to $657.1 million in 2019. Fetoscopes, fetal scalp electrodes and intrauterine pressure catheters achieved a market share of $76.2 million in 2013 and have the potential to earn $103.4 million in 2019.
Effective and timely utilization of fetal monitoring and diagnostic testing procedures bring about significant improvements in perinatal outcome. “Today, fetal medicine is a quickly growing field of expansive dimensions. The ever increasing development in fetal monitoring devices, prenatal diagnostic tests and neonatal surveillance technologies are enabling fetal medicine experts to foresee all the preventable fetal disorders beforehand,” says BCC Research analyst P. Natana Raj.
Fetal Monitoring, Diagnostics and Predictive Tests provides the current and projected markets for FHS monitors, fetal Dopplers, fetoscopes, fetal ultrasound systems, invasive prenatal diagnostics, noninvasive prenatal diagnostics, predictive diagnostics, preimplantation genetic diagnostics (PGD) and preimplantation genetic screening (PGS) tests.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
About BCC Research
BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today’s major industrial and technology sectors, including emerging markets. For more than 40 years we’ve helped customers identify new market opportunities with accurate and reliable data and insight, including market sizing, forecasting, industry overviews, and identification of significant trends and key market participants. We partner with analysts who are experts in specific areas of industry and technology, providing unbiased measurements and assessments of global markets. Recently selected as the world’s greatest market research company, BCC Research is a unit of Eli Global, LLC. Visit our website at http://www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern Time), or email information(at)bccresearch(dot)com.